Results 231 to 240 of about 3,183,958 (298)
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley +1 more source
Dual antihypertensive fixed-dose combinations approved for first-line use on the Pharmaceutical Benefits Scheme. [PDF]
europepmc +1 more source
Grocery store workers' knowledge, attitudes, and barriers influencing uptake of COVID-19 vaccine in the United States: a qualitative study. [PDF]
Kaur H +8 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Training Dental Researchers in Digital Outreach: A Course Model for Science Communication and Public Engagement. [PDF]
Rodrigues V.
europepmc +1 more source
A 2000-2023 dataset for measuring China's biodiversity risk. [PDF]
Chen ZH, Gao X, Yang JR, Yarovaya L.
europepmc +1 more source

